Operant Behavior and Alcohol Levels in Blood and Brain of Alcohol-Dependent Rats

被引:94
作者
Gilpin, Nicholas W. [1 ]
Smith, Amanda D. [1 ]
Cole, Maury [1 ]
Weiss, Friedbert [2 ]
Koob, George F. [1 ]
Richardson, Heather N. [1 ]
机构
[1] Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA
关键词
Alcohol Dependence; Blood-Alcohol Levels; Alcohol-Liquid Diet; Alcohol Vapor; ANXIETY-LIKE BEHAVIOR; BENZODIAZEPINE-RECEPTOR ANTAGONISTS; MULTIPLE ETHANOL WITHDRAWALS; CHRONIC INTERMITTENT ETHANOL; SOCIAL-INTERACTION; ANIMAL-MODEL; PROTRACTED ABSTINENCE; PHYSICAL-DEPENDENCE; DRINKING; STRESS;
D O I
10.1111/j.1530-0277.2009.01051.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
100404 [儿少卫生与妇幼保健学];
摘要
Background: The purpose of the present investigation was to more clearly define blood-alcohol parameters associated with alcohol dependence produced by alcohol vapor inhalation and alcohol-containing liquid diet. Methods: Alcohol levels in blood and brain were compared during and after 4 hours of acute alcohol vapor exposure; also, brain-alcohol levels were assessed in alcohol-exposed (14-day alcohol vapor) and alcohol-naive rats during and after 4 hours of acute alcohol vapor exposure. A separate group of rats were implanted with i.v. catheters, made dependent on alcohol via vapor inhalation, and tested for operant alcohol responding; blood-alcohol levels (BALs) were measured throughout operant alcohol drinking sessions during alcohol withdrawal. A final group of rats consumed an alcohol-liquid diet until they were dependent, and those rats were then tested for operant behavior at various withdrawal time points; BALs were measured at different withdrawal time points and after operant sessions. Results: Blood- and brain-alcohol levels responded similarly to vapor, but brain-alcohol levels peaked at a higher point and more slowly returned to zero in alcohol-naive rats relative to alcohol-exposed rats. Alcohol vapor exposure also produced an upward shift in subsequent operant alcohol responding and resultant BALs. Rats consumed large quantities of alcohol-liquid diet, most of it during the dark cycle, sufficient to produce high blood-alcohol levels and elevated operant alcohol responding when tested during withdrawal from liquid diet. Conclusions: These results emphasize that the key determinants of excessive alcohol drinking behavior are the BAL range and pattern of chronic high-dose alcohol exposure.
引用
收藏
页码:2113 / 2123
页数:11
相关论文
共 43 条
[1]
Baclofen efficacy in reducing alcohol craving and intake: A preliminary double-blind randomized controlled study [J].
Addolorato, G ;
Caputo, F ;
Capristo, E ;
Domenicali, M ;
Bernardi, M ;
Janiri, L ;
Agabio, R ;
Colombo, G ;
Gessa, GL ;
Gasbarrini, G .
ALCOHOL AND ALCOHOLISM, 2002, 37 (05) :504-508
[2]
REPEATED EPISODES OF ETHANOL WITHDRAWAL POTENTIATE THE SEVERITY OF SUBSEQUENT WITHDRAWAL SEIZURES - AN ANIMAL-MODEL OF ALCOHOL-WITHDRAWAL KINDLING [J].
BECKER, HC ;
HALE, RL .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1993, 17 (01) :94-98
[3]
Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior:: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist [J].
Breese, GR ;
Overstreet, DH ;
Knapp, DJ ;
Navarro, M .
NEUROPSYCHOPHARMACOLOGY, 2005, 30 (09) :1662-1669
[4]
Stress Sensitization of ethanol withdrawal-induced reduction in social interaction:: Inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A-receptor agonist [J].
Breese, GR ;
Knapp, DJ ;
Overstreet, DH .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (03) :470-482
[5]
Topiramate attenuates withdrawal signs after chronic intermittent ethanol in rats [J].
Cagetti, E ;
Baicy, KJ ;
Olsen, RW .
NEUROREPORT, 2004, 15 (01) :207-210
[6]
Caine SB., 1993, BEHAVIOURAL NEUROSCI, VSahgal A, P117
[7]
CLEMMESEN L, 1984, ACTA PHARMACOL TOX, V55, P345
[8]
Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x
[9]
Baclofen treatment for chronic posttraumatic stress disorder [J].
Drake, RG ;
Davis, LL ;
Cates, ME ;
Jewell, ME ;
Ambrose, SM ;
Lowe, JS .
ANNALS OF PHARMACOTHERAPY, 2003, 37 (09) :1177-1181
[10]
FRYE GD, 1981, J PHARMACOL EXP THER, V216, P306